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Background
Mammals encode proteins that inhibit viral replication at
the cellular level. In turn, certain viruses have evolved
genes that can counteract these intrinsic restrictions.
Human BST-2 (bone marrow stromal cell antigen 2, also
named CD317/HM1.24/tetherin) is recently identified an
IFN-induced antiviral protein that blocks release of
human immunodeficiency virus type 1 (HIV-1) from the
cell surface. This antiviral activity of BST-2 is counteracted
by HIV-1 Vpu. Our group as well as the others have gener-
ated data showing that Vpu antagonizes human BST-2
(hBST2) but not BST-2 from African green monkeys (agm
BST-2).
Methods and Results
Through mutagenesis study, we have mapped the deter-
minants of sensitivity to Vpu to several sites within the
transmembrane domain of agmBST-2, with deletion of
the 22-LL-23 residues conferring the highest degree of
resistance to Vpu. This resistance activity is further shown
as a result of a weak association of agmBST-2 or the
hΔLL22/23 mutant with Vpu and a refraction of these
BST-2 proteins to down-modulation by Vpu. With the aim
of assessing the involvement of the proteasome and the
lysosome degradation pathways in Vpu-mediated down-
modulation of hBST-2, specific proteasome inhibitors
and lysosome inhibitors were tested for their ability of res-
cuing hBST-2 expression in the presence of Vpu. The
results show that the proteasome inhibitors ALLN and
MG132 restore hBST-2 expression to the control level,
whereas, lysosome inhibitors chloroquine (CQ) or bafilo-
mycin A1 (BafA1) partially blocks down-modulation of
hBST2 by Vpu. To determine whether ubiquitination
serves as the signal that triggers hBST-2 down-modula-
tion, we first co-transfected the HA-ubiquitin DNA
together with hBST-2 DNA in the presence or absence of
Vpu. A specific HA-ubiquitin signal was not observed for
hBST-2 with Vpu expression. Moreover, when the only
two lysine residues (K18 and K21) within the cytoplasmic
domain of hBST-2 were mutated, the K(18,21)R mutant is
still sensitive to Vpu-induced down-modulation and is
unable to restrict production of wild type HIV-1.
Conclusion
Taken together, our results suggest that Vpu triggers hBST-
2 down-modulation mainly through the proteasome
pathway. The down-modulation event may be triggered
by signals other than direct ubiquitination of hBST-2.
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